JAMP Pharma Group is a Canadian organization headquartered in Boucherville, in the Greater Montreal area. Having experienced exceptional growth over the last 10 years, JAMP Pharma Group is active in all segments of the pharmaceutical market and now offers the largest selection of generic medications in Canada, with nearly 350 molecules.
This leadership in the generic drug sector significantly strengthens our long-term vision and our commitment to the health of Canadians. By increasing access to high-quality, lower-cost therapeutic options, we play a vital role in improving healthcare for everyone. Furthermore, our portfolio represents savings for the country's public and private healthcare systems, freeing up resources for other essential needs.
In addition to its generic division, JAMP Pharma Group owns several divisions and subsidiaries such as Orimed, BioJAMP®, JAMP Acute & Injectables and Wampole Group, offering prescription and brand-name products, biosimilars, and 180 over-the-counter products including a diverse range of vitamins, supplements, and natural health products. The JAMP Care™ patient support program is designed to assist patients and healthcare professionals with specialty medications and biosimilars offered by JAMP Pharma Group. Since 2024, JAMP Pharma Group has also operated its own manufacturing plant located in Lévis, Québec. JAMP Pharma Manufacturing supports continuous access to quality medications and health solutions for Canadians. In doing so, we are elevating our level of service for community pharmacies and hospitals, enabling them, in turn, to provide optimal service and continuity of care to their patients